Corifact 250 250 Unit (Factor Xiii POWDER FOR SOLUTION) 250 UNIT

CORIFACT 250 is a powder for solution containing Factor XIII, used for managing bleeding disorders. This intravenous medication supports blood clotting and is manufactured by CSL Behring Canada Inc.

Strength

250 UNIT

Manufacturer / TM Owner

CSL BEHRING CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CORIFACT 250 is primarily used to treat bleeding disorders associated with Factor XIII deficiency. This medication helps in the clotting process, which is essential for controlling bleeding episodes. It is often prescribed for individuals who have a genetic lack of Factor XIII, a protein crucial for blood coagulation. The solution is administered intravenously to ensure effective absorption and rapid action.

Side Effects

Common effects of CORIFACT 250 may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild to moderate discomfort during or after administration. It is important to monitor for any signs of allergic reactions, which can include rash, itching, or difficulty breathing. Always consult a healthcare provider if any adverse effects are observed.

Precautions & Warnings

CORIFACT 250 should be handled with care, ensuring proper storage and preparation to maintain its efficacy. It is crucial to follow the healthcare provider's instructions for administration and dosage. Individuals with known allergies to Factor XIII or any components of the solution should avoid using this medication. Always inform your healthcare provider about any pre-existing conditions or medications you are taking before starting treatment.

Avoid Interactions

CORIFACT 250 may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided as it can interfere with the medication's effectiveness. Always consult a healthcare provider for personalized advice on managing potential interactions.

Frequently Asked Questions

CORIFACT 250 is used to manage bleeding disorders associated with Factor XIII deficiency, supporting the blood clotting process.

CORIFACT 250 is administered intravenously as a powder for solution, prepared and injected by a healthcare professional.

Common effects may include localized reactions at the injection site, such as redness or swelling, and mild discomfort.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safe and effective use.

Individuals with known allergies to Factor XIII or any components of the solution should avoid using CORIFACT 250.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.